Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03693170
Title Encorafenib, Binimetinib and Cetuximab in Subjects With Previously Untreated BRAF-mutant ColoRectal Cancer (ANCHOR-CRC)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Pierre Fabre Medicament

colorectal cancer


Binimetinib + Cetuximab + Encorafenib

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | BEL | AUT

Additional content available in CKB BOOST